In France, radiopharmaceuticals preparation and dispensation are made under the responsibility of a pharmacist. This last one made a pharmaceutical over-specialization in the field of the medical use of radioelements. However, a flaw in the French law allows nuclear medicine units to avoid the presence of the radiopharmacist decreasing so the quality and the safety of the care brought to patients. This article aims at looking for legal solutions to maintain these quality and safety by the empowerment of the radiopharmacist statute while taking into account economic aspects.
CITATION STYLE
Doherty, J., & Graham, D. (2006). The Radiopharmacy. In Practical Nuclear Medicine (pp. 113–141). Springer London. https://doi.org/10.1007/1-84628-018-4_7
Mendeley helps you to discover research relevant for your work.